China SXT Pharmaceuticals Cash Flow Statement (2018-2025) | SXTC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2018	Sep2018	Mar2019	Sep2019	Mar2020	Sep2020	Mar2021	Sep2021	Mar2022	Sep2022	Mar2023	Sep2023	Mar2024	Sep2024	Mar2025	Sep2025
Operating Activities
Gains from Sales and Divestitures								2.33M			5.74M	0.30	8.03M	1.69M		22.78M
Non-cash Items														25.00		25.00
Change in Working Capital
Change in Receivables	2.60M		4.18M	-5.23M
Change in Account Payables	2.41M		1.69M	-1.57M	1.94M	-2.00M	1.46M	-1.48M	1.48M	-1.31M	1.38M	-1.30M	1.28M	-1.33M	1.16M	-1.18M
Change in Accured Expenses	0.42M		0.69M	-0.85M
Change in Taxes									1.17M	-1.04M	1.10M	-1.04M
Other Working Capital Changes	0.91M		0.71M	-3.16M									0.19M	-0.31M	0.06M	0.07M
Financing Activities
Debt Issuance and Repayment
Current Debt															0.42M	-2.29M
Net Debt Issuances and Repayments															0.42M	-2.29M
Additional items
Beginning Cash Balance	0.66M	0.58M	9.29M	9.29M	7.29M	7.29M	13.36M	13.36M	15.57M	15.57M	17.37M	17.37M	12.07M	12.08M	18.10M	18.13M